Global Head, Pricing and Market Access Cell Therapy

Astrazeneca

Within the AstraZeneca Cell Therapy Enterprise, our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units. Within the Cell Therapy Strategy and Commercial function, the Global Head, Pricing and Market Access plays a significant role in building and leading the global pricing, access and reimbursement strategies across multiple products. They, working cross-functionally within Cell Therapy and broadly with the global commercial teams in each TA, are responsible for developing and executing market access and pricing strategies that secure reimbursement for AstraZeneca’s life change Cell Therapy medicines. They also manage pricing and access inputs into long-range forecasts, ensuring payer related end-points are included in early and late stage evidence programs, as well as the delivery and execution of all global market access launch materials (i.e. Global Reimbursement Dossier, Global Payer Value Pack, Pricing Policies). The accountabilities of the Global Head, Pricing and Market Access require understanding of pricing and payer developments in all key markets to maintain a full, current view of external influences and their implications for products in Cell Therapy. In addition, they are expected to provide strategic guidance and advice to senior leadership on the impact of external changes and how to shape the payer landscape. Responsibilities: Provides strategic input to the vision and development of world class Cell Therapies. Has full and complete accountability for the successful development and execution of global price and access strategies, plans and tactics for all products in AstraZeneca Cell Therapy. Works with function, commercial franchise leadership, governance committees, global project teams and other internal partners to determine global payer (price and access) strategies, including: Providing key pricing and payer inputs into Therapeutic Area Strategies, Target Product Profiles, Clinical Development Plans, Integrated Development and Brand Plans. Representing Cell Therapy in key review and decision-making committees, including as applicable, Clinical Challenge, Therapeutic Area teams. Ensuring all relevant pricing, value issues and assumptions are integrated into and clearly visible in product forecasts and to SET for quarterly reporting and analyst calls. Oversees development and implementation of global pricing and reimbursement strategies and deliverables to meet payer needs for all payer archetypes and support markets to implement global price and reimbursement strategies at and beyond launch. Responsible for the development and maintenance of a robust company understanding of relevant pricing and reimbursement needs required by payers in key markets for assessment of products: Stays abreast of pricing and reimbursement trends to maintain a fully current view of internal and external influences and their implications for all molecules/products. Plays a lead role in educating other internal partners and stakeholders on evolutions, other dynamics and trends regarding payer practices for drug pricing, reimbursement, legislation and regulations, etc.  across key markets. Leads external payer policy shaping to improve payer landscape on key issues important to AstraZeneca. Maintains a high standard and level of knowledge and understanding regarding payer evidence requirements - scientific, clinical and commercial developments in the specific therapeutic area(s) of assignment, as well as continuous communication and effective partnering with global and marketing company cross-functional groups. Advances AstraZeneca’s reputation and expertise in pricing and reimbursement planning and evide